BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.17.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260819T140000
DTEND;TZID=America/Halifax:20260819T150000
DTSTAMP:20260816T162439Z
CREATED:20260816T162439Z
LAST-MODIFIED:20260816T162439Z
UID:10000921-1787148000-1787151600@oncodaily.com
SUMMARY:NCI The Genomic\, Host\, and Microenvironmental Determinants of Cancer Progression Webinar
DESCRIPTION:The Genomic\, Host\, and Microenvironmental Determinants of Cancer Progression webinar\, hosted by the National Cancer Institute (NCI)\, will take place virtually on 19 August 2026\, from 2:00 PM to 3:00 PM ET. \nThe session will feature Christina Curtis\, PhD\, MSc\, Professor of Medicine\, Genetics\, and Biomedical Data Science at Stanford University\, with Rao Divi\, PhD\, MSc\, Program Director in the Environmental Epidemiology Branch of NCI’s Epidemiology and Genomics Research Program\, serving as moderator. \nThe webinar will explore how tumor genomics\, inherited germline variation\, host immunity\, and the tumor microenvironment influence cancer progression and clinical outcomes. Topics will include long-term prediction of breast cancer recurrence using somatic copy-number alterations\, the role of Germline Epitope Burden (GEB) in immune recognition and tumor evolution\, and emerging approaches for studying premalignancy using CRISPR/Cas9-engineered organoids and high-resolution human tissue profiling. \nThe meeting will be held online and is intended for researchers and healthcare professionals interested in cancer genomics\, tumor evolution\, immunology\, and precision oncology.
URL:https://oncodaily.com/event/cancer-progression-webinar-567882
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/nci-logo-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260817
DTEND;VALUE=DATE:20260819
DTSTAMP:20260803T201402Z
CREATED:20260803T201246Z
LAST-MODIFIED:20260803T201402Z
UID:10000860-1786924800-1787097599@oncodaily.com
SUMMARY:2026 Hereditary Cancer Genetics: Incorporation into Clinical Care
DESCRIPTION:The 2026 Hereditary Cancer Genetics: Incorporation into Clinical Care conference\, hosted by Memorial Sloan Kettering Cancer Center (MSK)\, will take place on 17–18 September 2026 at the Zuckerman Research Center in New York City\, with both in-person and virtual attendance available. \nThe two-day programme will provide practical training in hereditary cancer genetics\, covering breast\, gynecologic\, gastrointestinal\, genitourinary\, pediatric\, and hematologic malignancies\, rare cancer syndromes\, genetic test interpretation\, surveillance\, risk reduction\, tumor profiling\, precision oncology\, early detection\, and prevention. The conference is designed for oncologists\, genetic counselors\, advanced practice providers\, nurses\, and other healthcare professionals and will include expert lectures\, multidisciplinary panels\, case-based sessions\, and networking. \nRegistration costs $300 for physicians\, $200 for advanced practice providers and genetic counselors\, $150 for trainees\, nurses\, and other healthcare professionals\, and $525 for industry professionals; MSK employees may attend free of charge.
URL:https://oncodaily.com/event/hereditary-cancer-genetics-558718
LOCATION:Mortimer B. Zuckerman Research Center\, 417 East 68th Street\, New York\, NY\, 10065\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-4-2026-12_11_20-AM.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260814T170000
DTEND;TZID=America/Halifax:20260814T180000
DTSTAMP:20260813T173151Z
CREATED:20260813T173151Z
LAST-MODIFIED:20260813T173151Z
UID:10000909-1786726800-1786730400@oncodaily.com
SUMMARY:Germline Predisposition and Acute Leukemia - Resonance
DESCRIPTION:The ALRCaN Global webinar\, “Germline Predisposition and Acute Leukemia\,” is scheduled for Friday\, August 14\, 2026\, from 9:00 AM to 10:00 AM ET (5:00 PM to 6:00 PM AMT). \nPresented by Anna Avagyan and organized by the Acute Leukemia Research and Care Network (ALRCaN)\, the webinar is part of the network’s weekly educational series featuring discussions on leukemia and supportive care topics. The series is supported by Scott Howard\, Stacy Cooper\, Archie Bleyer\, Dan Douer\, and the Resonance Team.
URL:https://oncodaily.com/event/germline-predisposition-565331
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/daa7bcc676908e9db22a7007c03a5dd5_exif.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260814T150000
DTEND;TZID=America/Halifax:20260814T170000
DTSTAMP:20260814T161017Z
CREATED:20260814T160906Z
LAST-MODIFIED:20260814T161017Z
UID:10000912-1786719600-1786726800@oncodaily.com
SUMMARY:The Evidence Synthesis Seminar Series: How to Critically Appraise a Case-Control Study
DESCRIPTION:The Evidence Synthesis Seminar Series: How to Critically Appraise a Case-Control Study\, jointly organized by NCODA\, the Faculty of Medical Sciences at Mohammed VI Polytechnic University (UM6P)\, and AORTIC\, will take place online on 14 August 2026\, from 15:00 to 17:00 GMT+1.  \nThe complimentary session will be presented by Nasser Laouali\, PhD\, from the Faculty of Medical Sciences at UM6P in Morocco\, and is designed for healthcare professionals\, biomedical and clinical researchers\, and students interested in strengthening their skills in evidence synthesis and critical appraisal. The session will focus specifically on the principles and practical considerations involved in critically appraising case-control studies. \nRegister.
URL:https://oncodaily.com/event/evidence-synthesis-seminar-566363
LOCATION:MD
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-14-2026-08_03_15-PM.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260814
DTEND;VALUE=DATE:20260816
DTSTAMP:20260725T215225Z
CREATED:20260725T215225Z
LAST-MODIFIED:20260725T215225Z
UID:10000832-1786665600-1786838399@oncodaily.com
SUMMARY:Louisiana Oncology Society 2026 Cancer Congress
DESCRIPTION:The LOS 2026 Cancer Congress: National Oncology Updates\, organized by the Louisiana Oncology Society (LOS)\, will take place on 14–15 August 2026 at the New Orleans Marriott Warehouse Arts District in New Orleans\, Louisiana. \nThe in-person congress will bring together oncology professionals from across the state to examine national and regional developments affecting cancer care\, including healthcare disparities\, emerging therapies\, treatment advances\, and challenges in oncology practice management. Through expert-led discussions and professional networking\, attendees will gain practical strategies to improve care delivery and patient outcomes while strengthening collaboration within Louisiana’s oncology community. \n 
URL:https://oncodaily.com/event/louisiana-oncology-society-2026-551036
LOCATION:New Orleans Marriott Warehouse Arts District\, 859 Convention Center Boulevard\, New Orleans\, 70130\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-26-2026-01_51_03-AM.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260813
DTEND;VALUE=DATE:20260817
DTSTAMP:20260730T165005Z
CREATED:20260730T165005Z
LAST-MODIFIED:20260730T165005Z
UID:10000845-1786579200-1786924799@oncodaily.com
SUMMARY:29th Annual Oncology Symposium for the Healthcare
DESCRIPTION:The 29th Annual Oncology Symposium for the Healthcare Provider\, organized by the Association of PAs in Oncology (APAO)\, will take place on 13–16 August 2026 at the New York Marriott Marquis in New York City. \nDesigned for oncology healthcare professionals\, the symposium will feature expert-led education\, practical discussions\, and updates across hematology and oncology\, radiation oncology\, and palliative and supportive care. Participants will be able to explore current best practices\, discover innovative approaches that can be incorporated into clinical practice\, connect with colleagues and industry experts\, and learn about emerging technologies and solutions from exhibitors and sponsors. APAO is the national professional organization representing physician associates working across oncology disciplines. \nRegister Today.
URL:https://oncodaily.com/event/oncology-symposium-for-the-healthcare-555266
LOCATION:New York Marriott Marquis\, 1535 Broadway\, New York\, NY\, 10036\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/association-of-physician-assistants-in-oncology-save-the-date-annual-oncology-symposium-new-york-city-august-2026-rectangle.webp
ORGANIZER;CN="Association of PAs in Oncology (APAO)":MAILTO:admin@apao.cc
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260813
DTEND;VALUE=DATE:20260816
DTSTAMP:20260805T221929Z
CREATED:20260805T221929Z
LAST-MODIFIED:20260805T221929Z
UID:10000870-1786579200-1786838399@oncodaily.com
SUMMARY:The 26th Asia-Pacific Prostate Cancer Conference - APCC 2026
DESCRIPTION:The 26th Asia-Pacific Prostate Cancer Conference (APCC 2026)\, hosted by the Australian Prostate Centre\, will take place on 13–15 August 2026 at the Melbourne Convention and Exhibition Centre in Melbourne\, Australia. \nThe multidisciplinary programme will bring together clinicians\, researchers\, nurses\, and allied health professionals to examine next-generation targeted therapies\, metastasis-directed treatment\, PSMA imaging and radionuclide therapy\, treatment intensification and sequencing\, immunotherapy\, artificial intelligence\, genomics\, survivorship\, sexual rehabilitation\, and health equity. \nGetz Healthcare will participate as an exhibitor at Booth 14\, presenting the NanoKnife System and TULSA-PRO System as examples of targeted ablation technologies used in prostate cancer care.
URL:https://oncodaily.com/event/prostate-cancer-560494
LOCATION:Melbourne Convention and Exhibition Centre (MCEC)\, 1 Convention Centre Place\, South Wharf\, Melbourne\, Victoria\, 3006\, Australia
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/apcc-2026-landscape.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260813
DTEND;VALUE=DATE:20260816
DTSTAMP:20260720T112913Z
CREATED:20260720T112913Z
LAST-MODIFIED:20260720T112913Z
UID:10000798-1786579200-1786838399@oncodaily.com
SUMMARY:2026 SNO/ASCO CNS Metastases Conference
DESCRIPTION:The 2026 SNO/ASCO CNS Metastases Conference\, organized by the Society for Neuro-Oncology (SNO) in collaboration with the American Society of Clinical Oncology (ASCO)\, will take place on 13–15 August 2026 at the Westin Copley Place in Boston\, Massachusetts. \nUnder the theme “From Moonshot to Groundshot: Transforming Science into Impact\,” the interdisciplinary programme will connect scientific discovery with clinical care across brain and leptomeningeal metastases. Key topics include CNS-active targeted therapies and immunotherapies\, precision neurosurgery\, stereotactic and FLASH radiotherapy\, device-based treatments\, toxicity management\, survivorship\, quality of life\, and data-driven decision-making. The event will also feature oral abstract presentations\, a poster networking reception\, and a complimentary workshop for early-career professionals and young investigators. Keynote speakers include Lizza Hendriks and Benjamin Izar. \nConference Registration.
URL:https://oncodaily.com/event/546557
LOCATION:The Westin Copley Place\, 10 Huntington Avenue\, Boston\, MA\, 02116\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-20-2026-03_17_19-PM.webp
ORGANIZER;CN="Society for Neuro-Oncology":MAILTO:melesa@soc-neuro-onc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260812
DTEND;VALUE=DATE:20260814
DTSTAMP:20260113T235414Z
CREATED:20260113T235354Z
LAST-MODIFIED:20260113T235414Z
UID:10000570-1786492800-1786665599@oncodaily.com
SUMMARY:NCODA Oncology Institute
DESCRIPTION:The NCODA Oncology Institute is an annual event that brings together healthcare providers and industry leaders to improve patient access and optimize oncology care delivery. \nThe 2026 meeting is scheduled for August 12–13\, 2026\, in Atlanta\, Georgia. It focuses on strengthening industry-practice partnerships and developing forward-thinking strategies to ensure timely medication delivery for cancer patients.
URL:https://oncodaily.com/event/ncoda-oncology-institute-440723
LOCATION:Omni Atlanta Hotel at Centennial Park\, 190 Marietta St NW\, Atlanta\, GA\, 30303\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/NCODA-Oncology-Institute.webp
ORGANIZER;CN="NCODA":MAILTO:contact@ncoda.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260811
DTEND;VALUE=DATE:20260812
DTSTAMP:20260803T194555Z
CREATED:20260803T194555Z
LAST-MODIFIED:20260803T194555Z
UID:10000858-1786406400-1786492799@oncodaily.com
SUMMARY:APPOS 2026: Advances in CAR T-Cell Therapy and Toxicity Management
DESCRIPTION:The networking CE dinner “CAR T-Cell Therapy in 2026: Advances in Safety\, Efficacy\, and Toxicity Management”\, presented by the Advanced Practice Providers Oncology Summit (APPOS)\, will take place on 11 August 2026 at Nick + Stef’s Steakhouse in Los Angeles\, California. \nThe two-hour educational programme will review CAR T-cell mechanisms\, recent strategies for reducing treatment-related toxicity\, efficacy data for FDA-approved therapies across hematologic malignancies\, and the recognition and management of established and emerging adverse effects. The event is primarily intended for nurse practitioners\, physician assistants\, pharmacists\, and nurses\, while physicians\, students\, and other healthcare professionals involved in oncology care are also welcome. Participants may earn continuing education credits and network with colleagues during the dinner.
URL:https://oncodaily.com/event/appos-558682
LOCATION:Nick + Stef’s Steakhouse\, 330 South Hope Street\, Los Angeles\, CA\, 90071\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-3-2026-11_45_16-PM.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260807T170000
DTEND;TZID=America/Halifax:20260807T180000
DTSTAMP:20260805T222206Z
CREATED:20260805T222206Z
LAST-MODIFIED:20260805T222206Z
UID:10000869-1786122000-1786125600@oncodaily.com
SUMMARY:Updates in Chronic Myeloid Leukemia in Adults and Children – Resonance
DESCRIPTION:The ALRCaN Global webinar\, “Updates in Chronic Myeloid Leukemia in Adults and Children\,” is scheduled for Friday\, August 7\, 2026\, from 9:00 AM to 10:00 AM ET (5:00 PM to 6:00 PM AMT). \nPresented by Scott Howard and organized by the Acute Leukemia Research and Care Network (ALRCaN)\, the webinar is part of the network’s weekly educational series featuring discussions on leukemia and supportive care topics. The series is supported by Scott Howard\, Stacy Cooper\, Archie Bleyer\, Dan Douer\, and the Resonance Team.
URL:https://oncodaily.com/event/chronic-myeloid-leukemia-559863
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/IMG_2408.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260807
DTEND;VALUE=DATE:20260809
DTSTAMP:20260803T193143Z
CREATED:20260803T193129Z
LAST-MODIFIED:20260803T193143Z
UID:10000857-1786060800-1786233599@oncodaily.com
SUMMARY:APP Cancer Research Summit 2026
DESCRIPTION:The APP Cancer Research Summit 2026\, presented by the Advanced Practice Providers Oncology Summit (APPOS)\, will take place on 7–8 August 2026 at the New York Marriott Marquis in New York City. \nDesigned specifically for advanced practice providers working across the oncology research continuum\, the two-day conference will cover clinical-trial fundamentals\, developing and leading independent research\, expanding the APP’s role within research teams\, and emerging trends in oncology research. The Summit will be held alongside the Summit for Novel Therapeutics in Oncology & Precision Medicine in Cancer (STOP Cancer)\, providing additional opportunities for education\, collaboration\, and networking.
URL:https://oncodaily.com/event/app-cancer-research-558653
LOCATION:New York Marriott Marquis\, 1535 Broadway\, New York\, NY\, 10036\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ACRS_logo_16x9_exact.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260807
DTEND;VALUE=DATE:20260809
DTSTAMP:20260614T151721Z
CREATED:20260614T151721Z
LAST-MODIFIED:20260614T151721Z
UID:10000761-1786060800-1786233599@oncodaily.com
SUMMARY:2026 Summit for Novel Therapeutics in Oncology and Precision Medicine in Cancer (STOP Cancer)
DESCRIPTION:The 2026 Summit for Novel Therapeutics in Oncology and Precision Medicine in Cancer (STOP Cancer) will bring together many of the world’s leading oncology researchers\, physician-scientists\, and clinical innovators on August 7-8\, 2026\, at the New York Marriott Marquis in Times Square. \nThe multidisciplinary conference is designed to bridge groundbreaking translational research with real-world patient care\, highlighting the latest advances in precision medicine\, targeted therapies\, antibody-drug conjugates (ADCs)\, biomarker-driven treatment strategies\, immunotherapy\, radiopharmaceuticals\, and early-phase clinical trials. The program will feature nationally recognized experts from leading institutions including Memorial Sloan Kettering Cancer Center\, Stanford Cancer Institute\, Mayo Clinic\, Dana-Farber Cancer Institute\, Vanderbilt University Medical Center\, MD Anderson Cancer Center\, and NEXT Oncology. \nAmong the distinguished faculty is Dr. Sarat Chandarlapaty of Memorial Sloan Kettering Cancer Center\, who will deliver the prestigious Daniel D. Von Hoff Keynote Lecture. Dr. Chandarlapaty is internationally recognized for his contributions to breast cancer research and precision oncology. \nThe summit also features an exceptional lineup of speakers who are helping define the future of cancer therapeutics\, including: \n• Dr. Vivek Subbiah\, Stanford Cancer Institute\, a globally recognized leader in drug development and precision oncology\, presenting on the evolution and future of tumor-agnostic therapies. \n• Dr. Eileen M. O’Reilly\, Memorial Sloan Kettering Cancer Center\, one of the nation’s foremost experts in gastrointestinal malignancies\, discussing recent precision medicine advances in GI cancers. \n• Dr. Alexander I. Spira\, Chief Scientific Officer of NEXT Oncology\, presenting emerging developments in RAS-targeted therapies and next-generation oncology drug development. \n• Dr. Anthony W. Tolcher\, Founder and CEO of NEXT Oncology and a pioneer in early-phase clinical trials\, discussing innovative approaches including RAS PROTACs and molecular glues. \n• Dr. Cathy Eng\, Vanderbilt University Medical Center and Co-Chair of the National Cancer Institute Gastrointestinal Steering Committee\, presenting on ctDNA applications and biomarker-driven management strategies in colorectal cancer. \n• Dr. Vamsi Velcheti\, Mayo Clinic\, an internationally recognized thoracic oncologist and cancer researcher\, discussing the development of antibody-drug conjugates in lung cancer. \n• Dr. Guru P. Sonpavde\, AdventHealth Cancer Institute\, a leading investigator in genitourinary oncology and phase I clinical research\, presenting on ADC innovation in GU malignancies. \n• Dr. Eytan Stein\, Memorial Sloan Kettering Cancer Center\, one of the nation’s leading leukemia drug development experts\, discussing precision medicine advances in myeloproliferative neoplasms. \n• Dr. Ghassan K. Abou-Alfa\, Memorial Sloan Kettering Cancer Center\, a globally respected authority in hepatobiliary cancers\, presenting emerging innovations in HER2-targeted therapy. \n• Dr. Ulka Vaishampayan\, University of Michigan Rogel Cancer Center\, discussing advances in alpha-emitter radiopharmaceutical therapies for prostate cancer. \nAdditional presentations will explore emerging TP53-targeted therapies\, PRMT5 inhibitors\, novel biomarker methodologies\, digital biomarkers\, clinical trial innovation\, patient-reported outcomes\, decentralized clinical trials\, and next-generation immunotherapy approaches. \n“The pace of innovation in oncology has never been greater\,” said Dr. Hani Babiker\, Course Director and Associate Professor of Medicine at Mayo Clinic. “STOP Cancer was created to provide a forum where clinicians\, researchers\, and healthcare professionals can engage directly with leaders developing the therapies and technologies that will shape the future of cancer care.” \nThe conference is intended for medical oncologists\, hematologists\, radiation oncologists\, surgical oncologists\, advanced practice providers\, pharmacists\, nurses\, fellows\, researchers\, and other healthcare professionals involved in cancer care. \nRegister now.
URL:https://oncodaily.com/event/precision-medicine-520908
LOCATION:New York Marriott Marquis\, 1535 Broadway\, New York\, NY\, 10036\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/06/Annotation-2026-06-14-191317.webp
ORGANIZER;CN="Horizon CME":MAILTO:info@horizoncme.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260801
DTEND;VALUE=DATE:20260806
DTSTAMP:20260727T120147Z
CREATED:20260727T120147Z
LAST-MODIFIED:20260727T120147Z
UID:10000834-1785542400-1785974399@oncodaily.com
SUMMARY:CGC 2026 Annual Meeting
DESCRIPTION:The 17th Annual Meeting of the Cancer Genomics Consortium\, organized by the Cancer Genomics Consortium (CGC)\, will take place on 1–5 August 2026 at The Royal Sonesta Houston Galleria in Houston\, Texas\, with both in-person and online participation available. \nThe meeting will focus on the latest scientific\, technological\, and clinical advances in cancer genomics and their application to patient care. The programme will begin with an Unconference\, followed by keynote lectures\, invited scientific sessions\, case-study presentations\, platform abstracts\, posters\, and round-table discussions. \nDedicated networking activities will include an early-career reception\, industry engagement\, and optional social events. Reduced registration fees will also be available to support participation from resource-limited countries. \nRegister Now.
URL:https://oncodaily.com/event/cgc-2026-552372
LOCATION:The Royal Sonesta Houston Galleria\, 2222 West Loop South\, Houston\, TX\, 77027\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-27-2026-03_56_51-PM.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260801
DTEND;VALUE=DATE:20260802
DTSTAMP:20251216T233150Z
CREATED:20251216T233138Z
LAST-MODIFIED:20251216T233150Z
UID:10000505-1785542400-1785628799@oncodaily.com
SUMMARY:OPN New Jersey - New York Chapter Conference 2026
DESCRIPTION:The 2026 OPN New Jersey – New York Chapter Conference is a regional oncology pharmacy summit scheduled for August 1\, 2026\, at the New York Marriott Marquis in New York City. \nHosted by the Oncology Pharmacy Network (OPN) and Horizon CME\, this collaborative event brings together hematology/oncology pharmacy clinicians – including pharmacists and pharmacy technicians – to network and discuss emerging agents\, updated clinical guidelines\, and strategies for optimizing patient care. \nRegister.
URL:https://oncodaily.com/event/opn-new-jersey-429684
LOCATION:New York Marriott Marquis\, 1535 Broadway\, New York\, NY\, 10036\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/OPN-New-Jersey-New-York.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260731T170000
DTEND;TZID=America/Halifax:20260731T180000
DTSTAMP:20260729T163038Z
CREATED:20260729T163038Z
LAST-MODIFIED:20260729T163038Z
UID:10000839-1785517200-1785520800@oncodaily.com
SUMMARY:FLT3-mutated AML: Biology and Treatment - Resonance
DESCRIPTION:The ALRCaN Global webinar\, “FLT3-Mutated AML: Biology and Treatment\,” is scheduled for Friday\, July 31\, 2026\, from 9:00 AM to 10:00 AM ET (5:00 PM to 6:00 PM AMT). \nPresented by Mark J. Levis and organized by the Acute Leukemia Research and Care Network (ALRCaN)\, the webinar is part of the network’s weekly educational series featuring discussions on leukemia and supportive care topics. The series is supported by Scott Howard\, Stacy Cooper\, Archie Bleyer\, Dan Douer\, and the Resonance Team.
URL:https://oncodaily.com/event/flt3-mutated-aml-553502
LOCATION:MD
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/IMG_9014.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260731
DTEND;VALUE=DATE:20260802
DTSTAMP:20260130T231749Z
CREATED:20260130T231749Z
LAST-MODIFIED:20260130T231749Z
UID:10000642-1785456000-1785628799@oncodaily.com
SUMMARY:Asia-Pacific Gastroenterology Cancer Summit (APGCS 2026)
DESCRIPTION:The Asia-Pacific Gastroenterology Cancer Summit (APGCS 2026) is scheduled to take place on July 31 and August 1\, 2026\, in Singapore. Themed “Translating Evidence into Action for GI Cancers\,” this 13th edition of the summit serves as a premier multidisciplinary platform for healthcare professionals\, researchers\, and clinicians to explore advancements in the diagnosis and management of gastrointestinal malignancies. \nCo-chaired by Toh Han Chong and Shaheenah Dawood\, the program features keynote lectures\, interactive debates\, and panel discussions led by a scientific committee that includes Pierce Chow\, Iain Tan\, Han Shuting\, Kai-Keen Shiu\, and Evelyn Wong. Early bird registration is available until April 30\, 2026\, providing delegates the opportunity to engage with world-renowned experts on cutting-edge research and next-generation therapeutics aimed at improving patient outcomes across the Asia-Pacific region.
URL:https://oncodaily.com/event/gastroenterology-cancer-summit-449628
LOCATION:Academia\, 20 College Road\, Singapore\, 169856\, Singapore
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/image-7.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260730T070000
DTEND;TZID=America/Halifax:20260801T130000
DTSTAMP:20260607T160959Z
CREATED:20260607T160959Z
LAST-MODIFIED:20260607T160959Z
UID:10000748-1785394800-1785589200@oncodaily.com
SUMMARY:35th Annual Mayo Clinic Hematology/Oncology Reviews 2026
DESCRIPTION:The 35th Annual Mayo Clinic Hematology/Oncology Reviews 2026 is scheduled for Thursday\, July 30 – Saturday\, August 1\, 2026\, offering both live in-person attendance at The Ritz-Carlton Amelia Island in Amelia Island\, Florida\, and livestream virtual options. \nLed by course directors Drs. Gerardo Colon-Otero\, Rami Manochakian\, and Stephanie Gebhardt\, APRN\, D.N.P.\, this comprehensive CME review is designed for practicing hematologists\, medical oncologists\, researchers\, and healthcare professionals. The interactive program focuses on the clinical application of new advancements\, practice-changing developments from 2025–2026\, and the risks and benefits of newly FDA-approved therapies to support optimal decision-making in daily practice. \nRegister Now.
URL:https://oncodaily.com/event/mayo-clinic-516831
LOCATION:The Ritz-Carlton Amelia Island\, 4750 Amelia Island Pkwy\, Amelia Island\, FL\, 32034\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/06/19849de5f1bb4629847cbb7bdd1b5c42-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260730
DTEND;VALUE=DATE:20260731
DTSTAMP:20260130T234148Z
CREATED:20260130T234141Z
LAST-MODIFIED:20260130T234148Z
UID:10000645-1785369600-1785455999@oncodaily.com
SUMMARY:Biomarkers and Precision Oncology Forum (BPOF 2026)
DESCRIPTION:The 4th Biomarkers and Precision Oncology Forum (BPOF 2026) is scheduled to take place on July 30\, 2026\, at Academia in Singapore. Organized by INDEX Conferences & Exhibitions\, this specialized one-day forum serves as a leading platform for exploring the latest innovations in precision medicine and targeted therapies across various malignancies\, including breast\, gastrointestinal\, genitourinary\, and lung cancers. \nThe event convenes international experts\, clinicians\, and researchers to discuss emerging trends in personalized cancer treatment and biomarker-driven care through keynote presentations and data-driven interactive sessions. Strategically held just before the Asia-Pacific Gastroenterology Cancer Summit (APGCS)\, BPOF 2026 aims to foster regional and global collaboration to advance the future of oncology care in the Asia-Pacific region.
URL:https://oncodaily.com/event/precision-oncology-449675
LOCATION:Academia\, 20 College Road\, Singapore\, 169856\, Singapore
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/BPOF.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260729T183000
DTEND;TZID=America/Halifax:20260729T183000
DTSTAMP:20260720T134131Z
CREATED:20260720T133509Z
LAST-MODIFIED:20260720T134131Z
UID:10000801-1785349800-1785349800@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases - Webinar Series: Rectal Cancer 2026
DESCRIPTION:The ESMO Guidelines: Real World Cases – Rectal Cancer 2026 webinar\, organized by the European Society for Medical Oncology (ESMO)\, will take place on 29 July 2026 at 18:30 CEST. \nThe session will use a real-world case to explore current ESMO recommendations for rectal cancer\, including multimodality treatment\, total neoadjuvant therapy\, organ preservation\, surgical strategies\, and personalised care. Speakers include Ralf Dieter Hofheinz\, Maximilian Kloft\, Francesco Sclafani\, and Marianne Gronlie Guren. The webinar is open to oncology healthcare professionals and requires an ESMO membership or free ESMO Account for registration. Live attendees will receive a certificate and one ESMO-MORA Category 1 point. \nRegister Now.
URL:https://oncodaily.com/event/rectal-cancer-2026-546680
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-20-2026-05_22_40-PM.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260729T110000
DTEND;TZID=America/Halifax:20260729T120000
DTSTAMP:20260710T132732Z
CREATED:20260710T132732Z
LAST-MODIFIED:20260710T132732Z
UID:10000787-1785322800-1785326400@oncodaily.com
SUMMARY:HER2 and Colorectal Cancer: What Advocates Need to Know
DESCRIPTION:HER2 and Colorectal Cancer: What Advocates Need to Know is a free webinar hosted by the Global Colon Cancer Association on Wednesday\, July 29\, 2026\, at 11am EDT (3:00pm UTC)\, designed to equip advocates with practical knowledge about HER2-positive colorectal cancer and the role biomarker testing can play in guiding care. \nThe webinar features John Strickler\, MD\, of Duke University\, Co-Leader of the Precision Cancer Medicine and Investigational Therapeutics Program\, Leader of the Molecular Tumor Board\, and Associate Director of Clinical Research – GI Oncology\, and Elle Charnisky\, colorectal cancer advocate and participant in the MOUNTAINEER clinical trial\, moderated by Nicole Sheahan\, President of the Global Colon Cancer Association. \nAttendees will learn what HER2 is and its role in colorectal cancer\, why biomarker testing matters\, how advocates can support patients in accessing biomarker testing\, how biomarker results may help identify clinical trial opportunities\, and the patient perspective on navigating precision medicine. \nRegister now.
URL:https://oncodaily.com/event/colorectal-cancer-539116
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/BeFunky-collage-2026-07-10T172420.090.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260729
DTEND;VALUE=DATE:20260801
DTSTAMP:20260302T103140Z
CREATED:20260302T103140Z
LAST-MODIFIED:20260302T103140Z
UID:10000679-1785283200-1785542399@oncodaily.com
SUMMARY:Breast Cancer Trials 47th Annual Scientific Meeting
DESCRIPTION:The Breast Cancer Trials (BCT) 47th Annual Scientific Meeting will be held from July 29–31\, 2026\, in Brisbane\, Queensland\, Australia. \nThis premier event brings together more than 1\,000 researchers across 118 institutions throughout Australia and New Zealand\, along with internationally renowned guest speakers\, to find new and better treatments and prevention strategies for breast cancer. The comprehensive three-day program features scientific sessions covering timely reviews of clinical trials\, discussion of new protocols\, and research developments\, including abstracts and debates. The meeting is followed by a Trainee and Early Career day on Saturday\, August 1\, 2026. \nRegister now.
URL:https://oncodaily.com/event/breast-cancer-trials-463304
LOCATION:Sofitel Brisbane Central\, 249 Turbot Street\, Brisbane\, Queensland\, 4000\, Australia
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/03/Annotation-2026-03-02-142412-1.webp
ORGANIZER;CN="Breast Cancer Trials":MAILTO:enquiries@breastcancertrials.org.au
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260728
DTEND;VALUE=DATE:20260731
DTSTAMP:20260722T151229Z
CREATED:20260722T151229Z
LAST-MODIFIED:20260722T151229Z
UID:10000817-1785196800-1785455999@oncodaily.com
SUMMARY:APOCP 13th General Assembly and Scientific Conference
DESCRIPTION:The 13th General Assembly and Scientific Conference\, organized by the Asian Pacific Organization for Cancer Prevention (APOCP)\, will take place on 28–30 September 2026 at The Waterfront Hotel in Kuching\, Sarawak\, Malaysia. \nThe three-day conference will feature a scientific programme focused on cancer prevention and research across the Asia-Pacific region. Registration and abstract submission details will be announced soon\, along with information on accommodation\, sponsorship\, and exhibition opportunities. Early-bird rates will be available for a limited period\, while groups of 10 or more participants and delegates selected for oral presentations may receive a 10% discount. Reduced registration categories will also be available for eligible students and non-governmental organisations\, subject to supporting documentation. \nRegister Now.
URL:https://oncodaily.com/event/apocp-548766
LOCATION:The Waterfront Hotel\, 68 Jalan Tun Abang Haji Openg\, Kuching\, Sarawak\, 93000\, Malaysia
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-22-2026-07_10_50-PM.webp
ORGANIZER;CN="Asian Pacific Organization for Cancer Prevention":MAILTO:apocpa13@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260727T110000
DTEND;TZID=America/Halifax:20260727T121500
DTSTAMP:20260607T152706Z
CREATED:20260607T152706Z
LAST-MODIFIED:20260607T152706Z
UID:10000742-1785150000-1785154500@oncodaily.com
SUMMARY:2026 NCCN Patient Webinar: Non-Small Cell Lung Cancer
DESCRIPTION:NCCN hosts a free patient webinar for individuals experiencing Non-Small Cell Lung Cancer\, their caregivers\, and their families is scheduled for Monday\, July 27\, 2026\, from 11:00 AM to 12:15 PM EDT as a virtual event. \nThe session is designed to help participants understand the disease and its treatment options\, engage in shared decision-making with their care teams\, and learn about clinical trials\, second opinions\, and patient-caregiver resources. The agenda features an expert panel presentation followed by a dedicated Question & Answer session\, led by presenters Dawn Owen\, MD\, PhD (Professor and Consultant at Mayo Clinic Comprehensive Cancer Center)\, Anna Schwecke\, MS\, APRN\, CNP\, OCN (Nurse Practitioner and Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center)\, and Beth Zaberdac\, MSW\, LCSW\, OSW-C (Manager of Community Engagement at the Lung Cancer Research Foundation). \nRegister Now.
URL:https://oncodaily.com/event/non-small-cell-lung-cancer-516766
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/06/BeFunky-collage-2026-06-07T192805.403.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260725
DTEND;VALUE=DATE:20260729
DTSTAMP:20260722T132518Z
CREATED:20260722T132518Z
LAST-MODIFIED:20260722T132518Z
UID:10000814-1784937600-1785283199@oncodaily.com
SUMMARY:AACR Conference on Pancreatic Cancer
DESCRIPTION:The AACR Conference on Pancreatic Cancer: New Frontiers in Biology and Therapeutic Development\, organized by the American Association for Cancer Research (AACR)\, will take place on 25–28 September 2026 at Hilton San Diego Bayfront in San Diego\, California. \nThe conference will bring together researchers\, clinicians\, industry experts\, and translational scientists to discuss advances in precision oncology\, KRAS-targeted therapies\, immunotherapy\, AI-driven research\, drug development\, clinical trial design\, and patient care. The programme aims to connect breakthrough science with clinical impact and strengthen collaboration across academia\, biotechnology\, pharmaceutical development\, and regulatory science. The advance registration deadline is 14 August 2026.
URL:https://oncodaily.com/event/pancreatic-cancer-548640
LOCATION:Hilton San Diego Bayfront\, 1 Park Boulevard\, San Diego\, CA\, 92101\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/HNct5zdXIAAQ4cV.webp
ORGANIZER;CN="American Association for Cancer Research":MAILTO:aacr@aacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260724T170000
DTEND;TZID=America/Halifax:20260724T180000
DTSTAMP:20260723T182323Z
CREATED:20260721T153533Z
LAST-MODIFIED:20260723T182323Z
UID:10000800-1784912400-1784916000@oncodaily.com
SUMMARY:First Line Treatment of Adults with Ph+ ALL. Intermediate Analysis of the ALLPh2022 Trial - Resonance
DESCRIPTION:The ALRCaN Global webinar\, “First-Line Treatment of Adults with Ph+ ALL: Interim Analysis of the ALLPh2022 Trial\,” is scheduled for Friday\, July 24\, 2026\, from 9:00 AM to 10:00 AM ET (5:00 PM to 6:00 PM Armenia Standard Time). \nPresented by Josep Maria Ribera and organized by the Acute Leukemia Research and Care Network (ALRCaN)\, the webinar is part of the network’s weekly educational series featuring discussions on leukemia and supportive care topics. The series is supported by Scott Howard\, Stacy Cooper\, Archie Bleyer\, Dan Douer\, and the Resonance Team.
URL:https://oncodaily.com/event/ph-all-546630
LOCATION:MD
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/Hana-2.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260724
DTEND;VALUE=DATE:20260729
DTSTAMP:20251107T221936Z
CREATED:20251107T221919Z
LAST-MODIFIED:20251107T221936Z
UID:10000328-1784851200-1785283199@oncodaily.com
SUMMARY:ESMO Course in Medical Oncology for Medical Students 2026
DESCRIPTION:The ESMO Course in Medical Oncology for Medical Students 2026 is an interactive\, four-day residential educational program taking place from July 24 to 28\, 2026\, in Valencia\, Spain. Organized by the European Society for Medical Oncology (ESMO)\, the course is specifically designed for fourth and fifth-year medical students. Co-Chaired by Andrés Cervantes and Rodrigo Sanchez Bayona (Spain)\, the course provides a high-standard\, interactive educational program—including state-of-the-art lectures\, clinical case discussions\, and dedicated workshops—with the primary goal of providing insight into the field of medical oncology and motivating students to commit to this fast-evolving specialty.
URL:https://oncodaily.com/event/esmo-course-404879
LOCATION:INCLIVA Biomedical Research Institute\, C. de Menéndez y Pelayo\, 4\, Valencia\, 46010\, Spain
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/11/esmo.png
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260722T083000
DTEND;TZID=America/Halifax:20260722T170000
DTSTAMP:20260522T094350Z
CREATED:20260522T094258Z
LAST-MODIFIED:20260522T094350Z
UID:10000736-1784709000-1784739600@oncodaily.com
SUMMARY:BTOG (British Thoracic Oncology Group) National Trials Meeting 2026
DESCRIPTION:The BTOG (British Thoracic Oncology Group) National Trials Meeting 2026 is scheduled for Wednesday\, July 22\, 2026\, from 08:30 AM to 05:00 PM at the Cavendish Conference Centre in London. \nThis full-day event is dedicated to the latest thoracic oncology treatment strategies\, emerging clinical evidence\, and new clinical trials shaping patient care across the UK. The comprehensive programme brings together leading UK experts to cover key advancements in EGFR and KRAS-mutant NSCLC\, antibody-drug conjugate (ADC)-based treatments\, small cell lung cancer\, mesothelioma\, rare cancers\, MRD-based treatment strategies\, and national trial development and delivery. \nThe meeting is open to a multidisciplinary audience\, including medical and clinical oncologists\, clinical fellows\, clinical nurse specialists\, research nurses\, trial coordinators\, data managers\, and research delivery staff. \nRegistration is free for eligible NHS and research institution staff.
URL:https://oncodaily.com/event/british-thoracic-oncology-group-506396
LOCATION:MD
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/05/BeFunky-collage-2026-05-22T134135.010.webp
ORGANIZER;CN="British Thoracic Oncology Group":MAILTO:info@btog.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260722T080000
DTEND;TZID=America/Halifax:20260722T090000
DTSTAMP:20260607T151052Z
CREATED:20260607T151052Z
LAST-MODIFIED:20260607T151052Z
UID:10000741-1784707200-1784710800@oncodaily.com
SUMMARY:Overcoming Challenges in High-Risk HR+/HER2- Early Breast Cancer Care
DESCRIPTION:The Team Strategies for Overcoming Challenges to Guideline-Concordant Care of High-Risk HR-Positive/HER2-Negative Early Breast Cancer workshop is scheduled for Wednesday\, July 22\, 2026\, from 8:00 AM to 9:00 AM Eastern Time (ET) as a virtual event\, hosted by the private host group NC in Hendersonville\, North Carolina\, United States. \nLed by faculty presenter Jame Abraham\, MD\, FACP (Enterprise Chairman\, Department of Hematology and Medical Oncology and Professor of Medicine at Cleveland Clinic)\, this multidisciplinary workshop will provide practical insights into optimizing care for patients with high-risk HR-positive/HER2-negative early breast cancer. The session is designed to meet the educational needs of oncologists\, nurse practitioners\, physician associates\, oncology nurses\, pharmacists\, and other healthcare professionals by focusing on identifying patients eligible for adjuvant CDK4/6 inhibitors\, aligning treatment decisions with NCCN Guidelines and pivotal trial data\, and personalizing therapy based on clinical and patient-specific factors. \nRegister Now.
URL:https://oncodaily.com/event/breast-cancer-516762
LOCATION:MD
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2024/11/IMG_0563.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260718T070000
DTEND;TZID=America/Halifax:20260718T160000
DTSTAMP:20260607T160523Z
CREATED:20260607T160523Z
LAST-MODIFIED:20260607T160523Z
UID:10000747-1784358000-1784390400@oncodaily.com
SUMMARY:Mayo Clinic Oncology Review 2026
DESCRIPTION:The Mayo Clinic Oncology Review 2026 is scheduled for Saturday\, July 18\, 2026\, offering both live in-person attendance at the InterContinental Minneapolis-St. Paul Airport in St. Paul\, Minnesota\, and livestream virtual options. \nLed by course director Dr. Thor Halfdanarson\, this one-day CME course provides hematology and oncology clinicians\, nurse practitioners\, and physician assistants with an overview of the most recent clinical advances based on abstracts from the American Society of Clinical Oncology (ASCO) annual meeting. The program focuses on interpreting and integrating practice-relevant data\, evidence-based immunotherapy strategies\, and biomarker-driven treatment decisions into daily practice. \nRegister Now.
URL:https://oncodaily.com/event/mayo-clinic-516820
LOCATION:InterContinental Minneapolis – St. Paul Airport\, 5005 Glumack Drive\, Minneapolis\, MN\, 55450\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/06/19849de5f1bb4629847cbb7bdd1b5c42-1.webp
END:VEVENT
END:VCALENDAR